Investors can explore detailed stock insights including earnings analysis, valuation metrics, and market momentum indicators across listed companies.
As of April 6, 2026, Pliant Therapeutics Inc. (PLRX) trades at $1.36, posting a mild 0.74% gain on the session. This analysis focuses on key technical levels and market dynamics shaping the biotech stock’s near-term trading activity, as no recent earnings data is available for the company at this time. PLRX, which focuses on developing novel therapies for fibrotic diseases, has traded in a tight range in recent weeks, with price action largely driven by broader sector sentiment and technical tra
Is Pliant Therapeutics (PLRX) Stock Lagging the Market | Price at $1.36, Up 0.74% - Volume Rate Change
PLRX - Stock Analysis
4418 Comments
1809 Likes
1
Roll
Returning User
2 hours ago
{协议答案}
👍 80
Reply
2
Karynne
New Visitor
5 hours ago
{协议答案}
👍 60
Reply
3
Yzabel
Loyal User
1 day ago
{协议答案}
4
Govind
Regular Reader
1 day ago
{协议答案}
👍 54
Reply
5
Olvie
Trusted Reader
2 days ago
{协议答案}
👍 166
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.